InDex Pharmaceuticals Holding AB (FLERIE) Stock Statistics & Valuation Metrics

InDex Pharmaceuticals Holding AB has a market cap or net worth of kr3.17B. The enterprise value is kr2.80B.

InDex Pharmaceuticals Holding AB has 78,066,410 shares outstanding. The number of shares has decreased by -2.65% in one year.

InDex Pharmaceuticals Holding AB’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -6.54%.

The current PE Ratio of InDex Pharmaceuticals Holding AB is -14.51. InDex Pharmaceuticals Holding AB’s PEG ratio is 0.18.

In the last 12 months, InDex Pharmaceuticals Holding AB had revenue of 100.00K and earned -228.00M in profits. Earnings per share was -3.24.

In the last 12 months, operating cash flow was -1.51M and capital expenditures 0.00, giving a free cash flow of -1.51M billion.

InDex Pharmaceuticals Holding AB pays an annual dividend of ―, resulting in a dividend yield of ―

InDex Pharmaceuticals Holding AB upcoming earnings date is May 7, 2025, TBA Not Confirmed.

InDex Pharmaceuticals Holding AB as a current ratio of 55.39, with Debt / Equity ratio of 0.02%

In the past 12 months, InDex Pharmaceuticals Holding AB has paid 100.00K in taxes.

InDex Pharmaceuticals Holding AB EV to EBITDA ratio is -10.82, with an EV/FCF ratio of -143.78.

InDex Pharmaceuticals Holding AB has kr802.10M in cash and marketable securities with kr800.00K in debt, giving a net cash position of -kr801.30M billion.

Gross margin is -18000.00%, with operating margin of -275000.00%, and net profit margin of -228000.00%.

The average price target for InDex Pharmaceuticals Holding AB is ―, which is 11.43% higher than the current price. The consensus rating is ―